These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 32577949)
1. Growth factor receptor bound protein-7 regulates proliferation, cell cycle, and mitochondrial apoptosis of thyroid cancer cells via MAPK/ERK signaling. Tang H; Yang P; Yang X; Peng S; Hu X; Bao G Mol Cell Biochem; 2020 Sep; 472(1-2):209-218. PubMed ID: 32577949 [TBL] [Abstract][Full Text] [Related]
2. [Knockdown of Grb7 inhibits growth of oral squamous cell carcinoma, cell proliferation and promoted apoptosis through ERK/FOXM1 pathway]. Liu BY; Cao G; Dong Z; Chen W; Xu JK; Zhang SL; Weng ZQ Shanghai Kou Qiang Yi Xue; 2016 Dec; 25(6):688-693. PubMed ID: 28275791 [TBL] [Abstract][Full Text] [Related]
3. Differential functions of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v in ovarian carcinogenesis. Wang Y; Chan DW; Liu VW; Chiu P; Ngan HY Clin Cancer Res; 2010 May; 16(9):2529-39. PubMed ID: 20388850 [TBL] [Abstract][Full Text] [Related]
4. TCF12-regulated GRB7 facilitates the HER2+ breast cancer progression by activating Notch1 signaling pathway. Wang G; Wu Y; Su Y; Qu N; Chen B; Zhou D; Yuan L; Yin M; Liu M; Zhou W J Transl Med; 2024 Aug; 22(1):745. PubMed ID: 39113057 [TBL] [Abstract][Full Text] [Related]
5. Methylation-associated silencing of Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818 [TBL] [Abstract][Full Text] [Related]
6. Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells. Chan DW; Hui WW; Cai PC; Liu MX; Yung MM; Mak CS; Leung TH; Chan KK; Ngan HY PLoS One; 2012; 7(12):e52578. PubMed ID: 23285101 [TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation of growth factor receptor-bound protein-7 by focal adhesion kinase in the regulation of cell migration, proliferation, and tumorigenesis. Chu PY; Huang LY; Hsu CH; Liang CC; Guan JL; Hung TH; Shen TL J Biol Chem; 2009 Jul; 284(30):20215-26. PubMed ID: 19473962 [TBL] [Abstract][Full Text] [Related]
8. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway. Xu J; Li Z; Su Q; Zhao J; Ma J Oncol Rep; 2017 Mar; 37(3):1555-1564. PubMed ID: 28098872 [TBL] [Abstract][Full Text] [Related]
9. A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC. Occhi G; Barollo S; Regazzo D; Bertazza L; Galuppini F; Guzzardo V; Jaffrain-Rea ML; Vianello F; Ciato D; Ceccato F; Watutantrige-Fernando S; Bisognin A; Bortoluzzi S; Pennelli G; Boscaro M; Scaroni C; Mian C Oncotarget; 2015 Oct; 6(31):32104-14. PubMed ID: 26392334 [TBL] [Abstract][Full Text] [Related]
10. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment]. Zhang YX; Kong CZ Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842 [TBL] [Abstract][Full Text] [Related]
11. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma. Yang R; Piperdi S; Gorlick R Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Cyclic Peptide Inhibitors of the Grb7 Breast Cancer Target: Small Change in Cargo Results in Large Change in Cellular Activity. Sang J; Kulkarni K; Watson GM; Ma X; Craik DJ; Henriques ST; Poth AG; Benfield AH; Wilce JA Molecules; 2019 Oct; 24(20):. PubMed ID: 31627265 [TBL] [Abstract][Full Text] [Related]
13. Upregulated GRB7 promotes proliferation and tumorigenesis of Bladder Cancer via Phospho-AKT Pathway. Zheng Y; Pei Y; Yang L; Zeng Z; Wang J; Xie G; Wang L; Yuan J Int J Biol Sci; 2020; 16(16):3221-3230. PubMed ID: 33162827 [TBL] [Abstract][Full Text] [Related]
14. E26 transformation (ETS)‑specific related transcription factor‑3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer. Chen H; Chen W; Zhang X; Hu L; Tang G; Kong J; Wang Z Oncol Rep; 2019 Jan; 41(1):570-578. PubMed ID: 30365150 [TBL] [Abstract][Full Text] [Related]
15. GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinoma. Gotovac JR; Liu DS; Yates MJ; Milne JV; Macpherson AA; Simpson KJ; Eslick GD; Mitchell C; Duong CP; Phillips WA; Clemons NJ J Pathol; 2020 Nov; 252(3):317-329. PubMed ID: 32737994 [TBL] [Abstract][Full Text] [Related]
16. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis. Tanaka S; Pero SC; Taguchi K; Shimada M; Mori M; Krag DN; Arii S J Natl Cancer Inst; 2006 Apr; 98(7):491-8. PubMed ID: 16595785 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA BCAR4 accelerates cell proliferation and suppresses cell apoptosis in gastric cancer via regulating MAPK/ERK signaling. Zhou GR; Huang DP; Sun ZF; Zhang XF Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3657-3664. PubMed ID: 32329841 [TBL] [Abstract][Full Text] [Related]
18. Grb7 and Hax1 may colocalize partially to mitochondria in EGF-treated SKBR3 cells and their interaction can affect Caspase3 cleavage of Hax1. Qian L; Bradford AM; Cooke PH; Lyons BA J Mol Recognit; 2016 Jul; 29(7):318-33. PubMed ID: 26869103 [TBL] [Abstract][Full Text] [Related]
19. GRB7 plays a promoting role in the progression of gastric cancer. Zhu G; Cai H; Xiao Q; Zeng S; Jiang X; Liu D BMC Cancer; 2023 Dec; 23(1):1262. PubMed ID: 38129809 [TBL] [Abstract][Full Text] [Related]
20. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways. Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]